FIELD: pharmaceuticals.
SUBSTANCE: claimed method includes composition containing mannan-binding lectin and treatment of conditions associated with deficit of mannan-binding lectin, causing susceptibility to infective disorders. Also disclosed is method for production of new expression structure encoding human mannan-binding lectin.
EFFECT: method for production of new human mannan-binding lectin.
47 cl, 8 ex, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NEW INDICATIONS FOR APPLYING MANNAN-BINDING LECTIN WHEN TREATING IMMUNE-COMPROMISED INDIVIDUALS | 2000 |
|
RU2273494C2 |
| METHOD FOR DETERMINING ACTIVITY OF MANNAN-BINDING LECTIN-ASSOCIATED SERINE PROTEASES IN A FIBRINOGEN COAGULATION TEST | 2019 |
|
RU2739113C1 |
| DETERMINING THE ACTIVITY OF THE CLASSICAL PATHWAY OF THE COMPLEMENT SYSTEM IN A FIBRINOGEN COAGULATION TEST | 2019 |
|
RU2707568C1 |
| RECOMBINANT LECTIN FROM WHITE MISTLETOE (RML) | 1996 |
|
RU2241750C2 |
| METHOD FOR ESTIMATION OF HUMAN BODY IMMUNE SYSTEM | 2006 |
|
RU2314529C1 |
| IMMUNOGENIC COMPOSITION AND METHOD OF FUSED PROTEIN VACCINE DEVELOPMENT | 2004 |
|
RU2407749C2 |
| CONSTRUCTED CELLS, EXPRESSING MULTIPLE IMMUNOMODULATORS, AND THEREOF APPLICATION | 2009 |
|
RU2573912C2 |
| POLYSACCHARIDE AND ITS DERIVATIVES WITH ACTIVITY TO FICOLIN-3, METHOD FOR OBTAINING AND APPLICATION THEREOF | 2011 |
|
RU2575752C2 |
| RECOMBINANT LENTIVIRAL VECTOR, HOST CELL TRANSDUCED WITH LENTIVIRAL VECTOR, METHODS FOR TRANSDUCTION AND USES THEREOF | 2002 |
|
RU2305708C2 |
| EXPRESSING CONSTRUCTION, EXPRESSING VECTOR PEDII CS150 AND METHOD FOR PRODUCING RECOMBINANT POLYPEPTIDE | 1999 |
|
RU2241035C2 |
